日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Discovery and Validation of a Novel Class of Necroptosis Inhibitors Targeting RIPK1.

发现并验证一类靶向 RIPK1 的新型坏死性凋亡抑制剂

Soday Lior, Seripracharat Chotima, Gray Janine L, Luz André F S, Howard Ryan T, Singh Ravi, Burden Thomas J, Bernardini Erika, Mateus-Pinheiro Miguel, Petersen Jens, Gunnarsson Anders, Gunnarsson Jenny, Aagaard Anna, Sjögren Tove, Maslen Sarah, Bartlett Edward J, Iles Abigail F, Smith David M, Scott James S, Skehel Mark, Davis Andrew M, Ressurreição Ana S, Moreira Rui, Rodrigues Cecília M P, Shenoy Avinash R, Tate Edward W

RIPK3 acts as a lipid metabolism regulator contributing to inflammation and carcinogenesis in non-alcoholic fatty liver disease

RIPK3作为一种脂质代谢调节因子,在非酒精性脂肪肝疾病中参与炎症和癌变过程。

Afonso, Marta B; Rodrigues, Pedro M; Mateus-Pinheiro, Miguel; Simão, André L; Gaspar, Maria M; Majdi, Amine; Arretxe, Enara; Alonso, Cristina; Santos-Laso, Alvaro; Jimenez-Agüero, Raul; Eizaguirre, Emma; Bujanda, Luis; Pareja, Maria Jesus; Banales, Jesus M; Ratziu, Vlad; Gautheron, Jeremie; Castro, Rui E; Rodrigues, Cecília M P